title: Spectrum of lithium induced thyroid abnormalities: a current perspective.
abstract: BACKGROUND
  Lithium is an integral drug used in the management of acute mania, unipolar and bipolar depression and prophylaxis of bipolar disorders. Thyroid abnormalities associated with treatment with lithium have been widely reported in medical literature to date. These include goitre, hypothyroidism, hyperthyroidism and autoimmune thyroiditis. This current review explores the varied thyroid abnormalities frequently encountered among patients on lithium therapy and their management, since lithium is still a fundamental and widely drug used in psychiatry and Internal Medicine.
  
  
  METHODS
  PubMed database and Google scholar were used to search for relevant English language articles relating to lithium therapy and thyroid abnormalities up to December 2012. The search terms used were lithium treatment, thyroid abnormalities, thyroid dysfunction, goitre, hypothyroidism, hyperthyroidism, thyrotoxicosis, autoimmune thyroiditis, lithium toxicity, treatment of affective disorders and depression and side effects of antipsychotic drugs. Reference lists of the identified articles were further used to identify other studies.
  
  
  RESULTS
  Lithium affects normal thyroid functioning through multiple mechanisms. At the cellular level, it decreases thyroid hormone synthesis and release. It also decreases peripheral deiodination of tetraiodothyronine (T4) or thyroxine by decreasing the activity of type I 5' de-iodinase enzyme. Hypothyroidism and goitre (clinically and/ultrasonographically detected) are the most prevalent thyroid abnormalities among patients on long term lithium therapy. Lithium induced hyperthyroidism is very infrequent. Lithium increases the propensity to thyroid autoimmunity in susceptible individuals due to its effect of augmenting the activity of B lymphocytes and reducing the ratio of circulating suppressor to cytotoxic T cells.
  
  
  CONCLUSIONS
  Thyroid function tests (serum thyroid stimulating hormone, free thyroid hormones-T4 and triiodothyronine [T3] concentrations and thyroid auto-antibodies) and assessment of thyroid size clinically and by thyroid ultrasonography ought to be performed among patients initiating lithium therapy at baseline and later annually. More frequent assessment of thyroid function status and size during the course of therapy is recommended among middle aged females (≥50 years), patients with a family history of thyroid disease and those positive for thyroid auto-antibodies (anti-thyroid peroxidase and TSH receptor antibodies).
authors: Department of Medicine, Uganda Martyrs Hospital Lubaga, Kampala, Uganda. davouirek@yahoo.co.uk.
authors: Davis
authors: D
authors: Kibirige
authors: Kenneth
authors: K
authors: Luzinda
authors: Richard
authors: R
authors: Ssekitoleko
references: Mol Psychiatry. 1999 Mar;4(2):117-28
references: 10208444
references: Clin Endocrinol (Oxf). 2001 Oct;55(4):501-8
references: 11678833
references: Am J Med. 2006 Jun;119(6):478-81
references: 16750958
references: Clin Endocrinol (Oxf). 1991 May;34(5):357-61
references: 2060144
references: Eur J Endocrinol. 2005 Dec;153(6):929-38
references: 16322400
references: Pharmacol Ther. 2010 Nov;128(2):281-304
references: 20705090
references: J Clin Psychopharmacol. 2001 Dec;21(6):594-8
references: 11763007
references: J Affect Disord. 2007 Dec;104(1-3):45-51
references: 17346802
references: J Thyroid Res. 2011;2011:306367
references: 21808723
references: Clin Endocrinol (Oxf). 1995 Jul;43(1):55-68
references: 7641412
references: J Affect Disord. 1998 Jul;50(1):33-40
references: 9716277
references: Lancet. 2012 Feb 25;379(9817):721-8
references: 22265699
references: Arq Bras Endocrinol Metabol. 2012 Apr;56(3):153-8
references: 22666729
references: Adv Ther. 2002 Jul-Aug;19(4):176-84
references: 12431043
references: Clin Pract Epidemiol Ment Health. 2006 Sep 12;2:23
references: 16968542
references: East Mediterr Health J. 2005 May;11(3):329-33
references: 16602451
references: Acta Psychiatr Scand. 1991 Mar;83(3):193-8
references: 1903238
references: J Endocrinol Invest. 2007 May;30(5):363-6
references: 17598966
references: Clin Immunol Immunopathol. 1982 Mar;22(3):400-7
references: 6286192
references: Best Pract Res Clin Endocrinol Metab. 2009 Dec;23(6):723-33
references: 19942149
references: QJM. 2012 Jan;105(1):83-5
references: 21177317
references: J Affect Disord. 2005 Aug;87(2-3):313-7
references: 16051025
references: CNS Drugs. 2009;23(4):331-49
references: 19374461
references: Clin Endocrinol (Oxf). 2011 Sep;75(3):402-3
references: 21521317
references: Lancet. 1974 Nov 16;2(7890):1160-3
references: 4139588
references: Am J Psychiatry. 1990 Nov;147(11):1518-21
references: 2221166
references: J Affect Disord. 2010 Nov;126(3):436-40
references: 20483164
references: Acta Psychiatr Scand. 1992 Jul;86(1):38-41
references: 1414397
references: Br J Psychiatry. 1999 Oct;175:336-9
references: 10789300
references: J Psychopharmacol. 2006 May;20(3):347-55
references: 16174674
references: Clin Endocrinol (Oxf). 1994 Jun;40(6):759-64
references: 8033366
references: Epidemiol Psichiatr Soc. 2006 Apr-Jun;15(2):123-7
references: 16865933
references: Acta Psychiatr Scand. 1996 Jul;94(1):45-8
references: 8841676
references: CNS Drugs. 2009 Dec;23(12):1003-21
references: 19958039
references: Neuropsychobiology. 1997;36(1):37-41
references: 9211443
references: Endocrinology. 1991 Aug;129(2):807-14
references: 1649747
references: Thyroid. 1998 Oct;8(10):909-13
references: 9827658
references: J Psychiatry Neurosci. 2005 Nov;30(6):423-7
references: 16327876
references: Am J Psychiatry. 2004 Feb;161(2):217-22
references: 14754766
references: Am J Psychiatry. 2005 Oct;162(10):1805-19
references: 16199826
references: Br Med J. 1968 Sep 21;3(5620):710-3
references: 17016877